| Application no. and date | 16710890.1 (espacenet) (Federated) (European Patent Register), 20160303 | | Patent/reg. no. and date | DK/EP 3265565, 20200812 | | Publication date | 20180110 | | Priority no. and date | US 201562128480 P, 20150304 | | EP pub. no. and date |
EP 3265565 20180110 | | Effective date | | | Applicant/owner | Board of Regents, The University of Texas System, 210 West 7th Street
Austin, Texas 78701, US | | Applicant ref. no. | P2859DKEP | | Inventor | LU, Xiongbin, 2422 Dorrington St.
Unit D
Houston, TX 77030, US,
LIU, Yunhua, 1229 N. Pennsylvania St.
Apt. 101
Indianapolis, IN 46202, US | | Representative | KIPA AB, Drottninggatan 11
SE-252 21 Helsingborg, SE | | Opponent | | | IPC Class | A61K 31/7088 (2006.01) , A61P 35/00 (2006.01) , C12N 15/113 (2010.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF CANCER, SOM HAR HEMIZYGOT TAB AF TP53 | | Int. application no. | US2016020687 | | Int. publication no. | WO2016141185 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
